CEO of Editas Medicine
Editas Medicine is a genome editing company founded in 2013 that is using CRISPR technology to treat patients with genetically defined diseases.
A biotechnology company developing drugs and treatments to diminish negative health effects associated with aging.
Aptinyx Inc. is a company developing treatments in neurology.